Bayer AG (BAYZF)
50.53
+1.04
(+2.11%)
USD |
OTCM |
Oct 06, 16:00
Bayer Gross Profit Margin (Quarterly) : 58.24% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 58.24% |
| March 31, 2026 | 60.97% |
| December 31, 2025 | 60.65% |
| September 30, 2025 | 55.41% |
| June 30, 2025 | 59.36% |
| March 31, 2025 | 59.06% |
| December 31, 2024 | 51.21% |
| September 30, 2024 | 48.94% |
| June 30, 2024 | 55.19% |
| March 31, 2024 | 60.31% |
| December 31, 2023 | 62.18% |
| September 30, 2023 | 53.47% |
| June 30, 2023 | 57.28% |
| March 31, 2023 | 60.16% |
| December 31, 2022 | 60.27% |
| September 30, 2022 | 62.35% |
| June 30, 2022 | 55.69% |
| March 31, 2022 | 64.64% |
| December 31, 2021 | 66.86% |
| September 30, 2021 | 60.26% |
| June 30, 2021 | 58.12% |
| March 31, 2021 | 61.89% |
| December 31, 2020 | 63.29% |
| September 30, 2020 | 20.12% |
| June 30, 2020 | 60.04% |
| Date | Value |
|---|---|
| March 31, 2020 | 63.75% |
| December 31, 2019 | 54.23% |
| September 30, 2019 | 61.52% |
| June 30, 2019 | 62.26% |
| March 31, 2019 | 60.28% |
| December 31, 2018 | 45.49% |
| September 30, 2018 | 55.72% |
| June 30, 2018 | 63.01% |
| March 31, 2018 | 68.17% |
| December 31, 2017 | 64.55% |
| September 30, 2017 | 68.04% |
| June 30, 2017 | 68.06% |
| March 31, 2017 | 69.14% |
| December 31, 2016 | 64.32% |
| September 30, 2016 | 67.11% |
| June 30, 2016 | 57.51% |
| March 31, 2016 | 57.45% |
| December 31, 2015 | 52.18% |
| September 30, 2015 | 55.11% |
| June 30, 2015 | 56.12% |
| March 31, 2015 | 53.90% |
| December 31, 2014 | 50.66% |
| September 30, 2014 | 51.25% |
| June 30, 2014 | 51.20% |
| March 31, 2014 | 54.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| SenesTech, Inc. | 69.74% |
| Dermapharm Holding SE | 33.36% |
| Johnson & Johnson | 68.73% |
| Merck & Co., Inc. | 71.51% |
| Pfizer Inc. | 62.94% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -5.88% |
| Return on Assets | -1.59% |
| Return on Invested Capital | -2.52% |
| Profit Margin (Quarterly) | 2.11% |
| Operating Margin (Quarterly) | 8.18% |
| Return on Net Operating Assets | -2.00% |